858 THERAPEUTICS
858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. The company was founded in 2019 and is headquartered in San Diego, California, USA.
858 THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.8five8tx.com
Total Employee:
11+
Status:
Active
Contact:
(858) 987-8380
Email Addresses:
[email protected]
Total Funding:
80.06 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag Google Apps For Business US Privacy User Signal Mechanism
Similar Organizations
Acclinate
Acclinate is a digital health company helping pharma diversify clinical trials by accessing and engaging communities of color.
Arcuate Therapeutics
Arcuate Therapeutics is a provider of stealth healthcare service.
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Immuto Scientific
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Lifestores Pharmacy
Lifestores Pharmacy is a retail pharmacy start-up bringing disruptive innovation to the pharmaceutical sector.
Zikani Therapeutics
Zikani Therapeutics is a new anti-infective company founded to advance groundbreaking technology.
Medimall
Medimall is an IoT enabled online health companion offering virtual healthcare services.
Theralink Technologies
Theralink Technologies is a molecular company specializing in patented, biomarker assay services that target multiple areas of oncology.
PharmaCircle
PharmaCircle is a knowledge management company specializing in the drug delivery, pharmaceutical, and biotechnology fields.
PharmaTher
PharmaTher is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
PRA Health Sciences
PRA Health Sciences provides product development and data solution services to pharmaceutical and biotechnology companies.
Provell Pharmaceuticals
Provell Pharmaceuticals is a healthcare company that specializes in the marketing and distribution of pharmaceutical products.
Psycheceutical
Psycheceutical is a patented delivery technology that provides safe bioavailable psychedelic pharmaceutical medicines.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Think Biosolution
Chronic disease prevention platforms for assisted living and home health care & home health care agencies
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-21 | Gotham Therapeutics | Gotham Therapeutics acquired by 858 Therapeutics | N/A |
Investors List
New Enterprise Associates
New Enterprise Associates investment in Series A - 858 Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series A - 858 Therapeutics
Versant Ventures
Versant Ventures investment in Series A - 858 Therapeutics
Logos Capital
Logos Capital investment in Series A - 858 Therapeutics
Official Site Inspections
http://www.8five8tx.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: 199.36.158.100
- IP address: 199.36.158.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "858 Therapeutics"
Leadership Team | About Us | 858 Therapeutics
While at AbbVie, she led the clinical science group in early development in oncology as well as the Oncology Early Development (OED) cross-functional organization prior to joining 858. Kathy received a B.S. in Chemistry and a …See details»
858 Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (858) 987-8380 858 Therapeutics is a biotechnology company focused on discovering small molecule therapeutics for novel targets in oncology and immunology.See details»
Board of Directors | About Us | 858 Therapeutics
Prior to joining Prelude, she served as Chief Medical Officer of Hematology at BeiGene, Ltd., where she created a global development organization encompassing clinical pharmacology to global product safety and had …See details»
858 Therapeutics - LinkedIn
858 Therapeutics | 1,697 followers on LinkedIn. Discovering innovative small molecule therapeutics for the treatment of cancer | 858 Therapeutics is a biotechnology and drug discovery company ...See details»
858 Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials
For more information, please visit www.8five8tx.com . Phase 1 PROTACs. 26 Sep 2024 ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted …See details»
858 Therapeutics - VentureRadar
"858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that …See details»
858 Therapeutics Launches with Proven Team and $60 …
Sep 21, 2021 For more information, please visit www.8five8tx.com. About Versant Ventures Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs build the ...See details»
858 Therapeutics Expands Leadership Team to Support ... - BioSpace
Dec 20, 2023 SAN DIEGO--(BUSINESS WIRE)-- 858 Therapeutics, Inc. is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical Officer.The …See details»
858 Therapeutics Expands Board of Directors and …
Apr 5, 2022 For more information, please visit www.8five8tx.com. Contacts. Steve Edelson [email protected] 415-801-8088 Contacts. Steve Edelson [email protected] 415-801-8088See details»
858 Therapeutics Expands Leadership Team to Support …
Dec 20, 2023 For more information, please visit www.8five8tx.com. Contacts. Steve Edelson [email protected] 415-801-8088 Contacts. Steve Edelson [email protected] 415-801-8088See details»
Contact | 858 Therapeutics - 8five8tx.com
858 Therapeutics 3115 Merryfield Row, Suite 110 San Diego, CA 92121See details»
858 Therapeutics to Present Preclinical Data on ETX-19477 at the …
SAN DIEGO, March 14, 2024--858 Therapeutics today announced an upcoming poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, …See details»
858 Therapeutics Launches with Proven Team and $60 Million
Sep 21, 2021 SAN DIEGO--(BUSINESS WIRE)--858 Therapeutics, Inc. today exited stealth mode with a $60 million Series A financing led by founding investor Versant Ventures, with …See details»
858 Therapeutics and OpenBench Launch Small Molecule Drug …
Nov 4, 2024 For more information, please visit www.8five8tx.com. About OpenBench. ... VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization …See details»
Careers | 858 Therapeutics - 8five8tx.com
Thinking about joining 858 Therapeutics? Browse our openings below and apply online!See details»
Trinna L. Cuellar, PhD, MBA’s Post - LinkedIn
Https://8five8tx.com #gothamtheraputics #innateimmunity #nycbiotech #mettl3 https://lnkd.in/dGbgmzAS 858 Therapeutics launches with $60 million and acquisition of …See details»
Pipeline | 858 Therapeutics - 8five8tx.com
At 858 Therapeutics, we are advancing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology and immunology. We leverage our deep expertise in structure …See details»
858 Therapeutics to Present Preclinical Data on ETX-19477 at the …
Mar 14, 2024 For more information, please visit www.8five8tx.com. Contacts. Steve Edelson [email protected] 415-801-8088 Contacts. Steve Edelson …See details»
News | 858 Therapeutics - 8five8tx.com
Sep 21, 2021 November 4, 2024 858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery Collaboration; September 26, 2024 858 Therapeutics Announces $50 Million …See details»